IPC Subgroup
A61K 40/1 characterised by the cell type used
Introduced: January 2025
Full Title
Cellular immunotherapy > characterised by the cell type used
Classification Context
- Section:
- HUMAN NECESSITIES
- Class:
- MEDICAL OR VETERINARY SCIENCE; HYGIENE
- Subclass:
- PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
5 direct subcodes
Child Classifications
Navigate with arrow keys, Enter to open
- A61K 40/11 T-cells, e.g. tumour infiltrating lymphocytes [TIL] or regulatory T [Treg] cells; Lymphokine-activated killer [LAK] cells
- A61K 40/13 B-cells
- A61K 40/15 Natural-killer [NK] cells; Natural-killer T [NKT] cells
- A61K 40/17 Monocytes; Macrophages
- A61K 40/19 Dendritic cells
Top Applicants
Top 10 applicants by patent filingsfor class A61, 2013–2023, worldwide · Source: EPO PATSTAT
- PHILIPS ELECTRONICS NL 18,523
- NOVARTIS CH 14,253
- COVIDIEN US 13,953
- ROCHE CH 12,005
- CHINESE ACADEMY OF SCIENCES 11,955
- UNIVERSITY OF CALIFORNIA US 11,692
- HARVARD UNIVERSITY US 11,596
- L'OREAL FR 11,593
- P&G (PROCTER & GAMBLE COMPANY) US 11,297
- OLYMPUS CORPORATION JP 9,594